# TG Therapeutics, Inc.: Form DEF 14A, filed Apr 30, 2026

- Company: [TG Therapeutics, Inc.](/companies/tgtx.md) (CIK 1001316)
- Form: DEF 14A
- Filed: 2026-04-30
- Accepted by EDGAR: Apr 30, 2026, 16:31 ET
- Period: 2026-06-11
- Accession: 0001437749-26-014233
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1001316/000143774926014233/tgtx20260301_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1001316/000143774926014233/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1001316/000143774926014233/tgtx20260301_def14a.htm

Filed Apr 30, 2026.
Source: SEC EDGAR, the filing index for accession 0001437749-26-014233. Last ingested by Listed: Oct 24, 2026, 15:01 ET. No prices; not investment advice.